Frontiers in Cardiovascular Medicine

MARCH 3, 2025

IntroductionSystemic inflammation is recognised as a critical driver of atherosclerotic cardiovascular disease (ASCVD), especially in patients with comorbid chronic kidney disease (CKD).

Kidney Disease 52

Kidney Disease Cardiovascular Disease Cholesterol Obesity 52

The British Journal of Cardiology

OCTOBER 8, 2024

Sodium-glucose cotransporter type 2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists are established glucose-lowering and weight-lowering agents used in the management of type 2 diabetes mellitus and obesity.

Obesity 40

Obesity Diabetes Kidney Disease Heart Failure 40

Medical Xpress - Cardiology

FEBRUARY 18, 2025

adults meet the criteria for a newly recognized syndrome that comes from a combination of heart disease, kidney disease, type 2 diabetes and obesity. This cluster of chronic health conditions is called cardiovascular-kidney-metabolic (CKM) syndrome. About 90% of U.S.

Kidney Disease 55

Kidney Disease Obesity Heart Disease Diabetes 55

Cardiometabolic Health Congress

NOVEMBER 25, 2024

Don’t worry—you can still access the 19th Annual CMHC sessions through our On-Demand platform, which offers 14 CME credits across four comprehensive tracks: Cardiorenal Health: Stay up-to-date with the latest on therapies for resistant hypertension, chronic kidney disease markers, and cardiac risk assessment tools.

CME 52

CME Obesity Certification Education 52

Cardiometabolic Health Congress

JULY 25, 2023

Can you please explain the concept of an obesity paradox? Salvatore Carbone, PhD: First, I’d like to point out that obesity is a major risk factor for cardiometabolic disease. 2, 3] This association is more pronounced for those with class I obesity, which is a body mass index (BMI) between 30-35 kg/m2.

Obesity 52

Obesity BMI Heart Failure Cardiovascular Disease 52

MIBHS

FEBRUARY 15, 2025

Secondary hypertension : This type results from an underlying condition such as kidney disease, hormonal disorders, or the use of certain medications. High blood pressure can be classified into two categories: Primary hypertension : This type develops gradually over time without an identifiable cause.

Blood Pressure 52

Blood Pressure Hypertension Chest Pain ACE Inhibitor 52

American College of Cardiology

FEBRUARY 12, 2024

What is the value of the new American Heart Association’s (AHA’s) PREVENT equation(s) for primary prevention that use routinely available clinical variables including obesity, diabetes, kidney disease, and social risk for predicting 10- and 30-year absolute risk of cardiovascular disease (CVD) including each atherosclerotic CVD (ASCVD) and heart (..)

Kidney Disease 49

Kidney Disease Obesity Heart Failure Cardiovascular Disease 49

Circulation

JANUARY 24, 2024

METHODS:The AHA, through its Epidemiology and Prevention Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States and globally to provide the most current information available in the annual Statistical Update with review of published literature through the year before writing.

Heart Disease 81

Heart Disease Peripheral Arterial Disease Stroke Strokes 81

Cardiometabolic Health Congress

JULY 25, 2024

Practical, Future-Focused Education Cardiorenal and metabolic diseases, fueled by poor lifestyle choices and health conditions, lead to type 2 diabetes, cardiovascular disease, and chronic kidney disease. The future of care demands a holistic approach.

Education 100

Education Innovation Risk Factors Obesity 100

CardiacWire

OCTOBER 27, 2024

It’s well known that heart disease is the U.S.’s s top cause of death, and our rising CVD rates have been widely covered, but a look back on some of the biggest stories of 2024 suggests that cardiovascular disease is about to become a much bigger problem. trillion, representing 4.6% of US GDP.

AFIB 59

AFIB Hypertension Kidney Disease Heart Disease 59

Frontiers in Cardiovascular Medicine

OCTOBER 9, 2024

Additionally, restricted cubic splines (RCS) analysis was also employed.ResultsWe found that those with AAC were significantly older and had a higher prevalence of smoking and chronic kidney disease (CKD) prevalence compared to those without AAC.

Aortic 52

Aortic Obesity Kidney Disease Public Health 52

Cardiometabolic Health Congress

JUNE 24, 2024

The session will detail the results of a webcast series on better managing obesity in patients with type 2 diabetes, significantly improving their knowledge and treatment practices. The program led to increases in knowledge and competence regarding new weight management therapies and effective long-term obesity treatment.

Patient Care 52

Patient Care Obesity Education CME 52

DAIC

SEPTEMBER 11, 2024

A-Fib, as the condition is commonly known, has been on the rise for at least the past decade, driven by the aging of the population, along with increasing rates of hypertension, diabetes and obesity. Earlier projections had estimated that 3.3 million U.S. The study appears Sept. 11 in the Journal of the American College of Cardiology JACC.

Atrial Fibrillation 92

Atrial Fibrillation Quality of Life Myocardial Infarction Kidney Disease 92

Cardiometabolic Health Congress

NOVEMBER 8, 2023

2023, the American Heart Association (AHA) issued a presidential advisory on the urgency of this systemic disorder involving heart disease, kidney disease, diabetes and obesity. The virtual, self-paced Foundations of Cardiometabolic Health Certificate Course is the first step to attaining the CCHP credential. Robert H.

Certification 52

Certification Nursing Kidney Disease Education 52

Cardiometabolic Health Congress

JULY 12, 2023

For instance, a pediatric provider may be only interested in topics pertaining to childhood obesity. They could find resources and education focused on that condition within both the Obesity Management and Pediatrics hubs.

Education 40

Education Webinar CME Pediatrics 40

Circulation: Heart Failure

MARCH 8, 2024

The prevalence of HF risk factors was high: hypertension, 61.9%; former or current smoking, 53.7%; obesity 34.8%; diabetes; 24.7%; and chronic kidney disease; 22%. Overt cardiovascular disease, which ranged from 2.1% (HF) to 13.6% (atrial fibrillation), was less common. were female, 25.6% were Black, 12.8% were White.

Heart Failure 40

Heart Failure Atherosclerosis Kidney Disease Risk Factors 40

European Journal of Heart Failure

DECEMBER 22, 2023

1.65), chronic kidney disease (HR 1.37, 95%CI 1.34-1.41), 1.41), chronic obstructive pulmonary disease (HR 1.32, 95%CI 1.28-1.35). Obesity was associated with a lower risk of all-cause death (HR 0.81, 95%CI 0.79-0.84). The highest risk was associated with dementia (hazard ratio [HR] 1.55, 95% confidence interval [CI] 1.45-1.65),

Heart Failure 40

Heart Failure Coronary Artery Disease Kidney Disease Dementia 40

Cardiometabolic Health Congress

AUGUST 14, 2024

Themed “Decoding the Constellation of Cardiometabolic Health and Risk Factors,” this year’s congress will tackle the growing health threat posed by cardiometabolic diseases, affecting 47 million people in the US. Singh, MBBS, FRCP, MBA Advances in Obesity Pharmacotherapy Louis J.

CME 72

CME Education Diabetes Innovation 72

Circulation

NOVEMBER 11, 2024

A 35-year-old gravida 1, para 0 with biventricular heart failure (LVEF 25%), nonischemic cardiomyopathy, history stroke, history of left ventricular thrombus, class III obesity, and chronic kidney disease who had been followed by Cardio-Obstetrics throughout her pregnancy presented at 34 weeks gestation for planned induction of labor.

Heart Failure 40

Heart Failure Cardiogenic Shock ICU Cardiothoracic 40

DAIC

SEPTEMBER 11, 2024

A-Fib, as the condition is commonly known, has been on the rise for at least the past decade, driven by the aging of the population, along with increasing rates of hypertension, diabetes and obesity. Earlier projections had estimated that 3.3 million U.S. The study appears Sept. 11 in the Journal of the American College of Cardiology JACC.

Atrial Fibrillation 52

Atrial Fibrillation Quality of Life Myocardial Infarction Kidney Disease 52

Stroke Journal

FEBRUARY 1, 2024

to 2.26) and liver disease (OR 2.20, p < 0.01, CI 1.27 Regarding comorbidities, congestive heart failure (OR 1.73, p <0.01, CI 1.32

Inpatient 40

Inpatient Stroke Strokes Coronary Artery Disease 40

Cardiometabolic Health Congress

OCTOBER 26, 2023

A session at the 18 th Annual Cardiometabolic Health Congress (CMHC), explored the intersection of cardiometabolic conditions such as obesity and insulin resistance with liver disease, beginning with some important new updates on the preferred terms for these diseases. Nonalcoholic fatty liver disease (NAFLD) & NASH.

Diabetes 52

Diabetes Kidney Disease Obesity Anatomy 52

DAIC

DECEMBER 8, 2023

“The new guideline reinforces the urgent need to approach AFib as a complex cardiovascular condition that requires disease prevention, risk factor modification, as well as optimizing therapies and patients’ access to care and ongoing, long-term management.” For example, kidney disease is not included in CHA 2 DS 2 -VASc.

Atrial Fibrillation 52

Atrial Fibrillation AFIB Stroke Strokes 52

GEMMS

MAY 22, 2024

Gene-Based Analysis Predictive analytics is vital in reducing morbidity and mortality, with healthcare startups focusing on early risk prediction and disease detection. Much of heart disease is linked to conditions like diabetes, obesity, or chronic kidney disease, and specific mutations in nucleic acids help identify them.

Heart Disease 52

Heart Disease Blood Pressure Technology Innovation 52

DAIC

JANUARY 23, 2024

11 Despite the link between inflammation and cardiovascular disease has been proven by extensive research, most physicians have focused on treating high-risk patients with lipid lowering therapies including statin therapy.1,12,13 For most individuals, these gastrointestinal effects markedly attenuate with longer-term therapy.34 μ/L on 0.6

Cardiovascular Disease 111

Cardiovascular Disease Heart Attack Heart attacks Coronary Artery Disease 111

Physiologically Speaking

DECEMBER 15, 2023

For adults with overweight and obesity, resistance exercise increases lean body mass and reduces body fat percentage and fat mass — improving overall body composition. Of course, these benefits can also extend to individuals with a BMI in the normal range. RT Prescription Resistance training need not be complicated to be effective.

Physiology 52

Physiology Exercise Blood Pressure Risk Factors 52

Physiologically Speaking

DECEMBER 15, 2023

For adults with overweight and obesity, resistance exercise increases lean body mass and reduces body fat percentage and fat mass — improving overall body composition. Of course, these benefits can also extend to individuals with a BMI in the normal range. RT Prescription Resistance training need not be complicated to be effective.

Physiology 52

Physiology Exercise Blood Pressure Risk Factors 52

Physiologically Speaking

FEBRUARY 26, 2024

And that’s exactly when obesity began a meteoric rise. Another study found that they don’t get diabetes and kidney diseases (the ninth leading cause of death). But the food industry started leveraging it with the rise of ultraprocessed snack foods in the 1970s. I write about nutrition quite a bit.

Diet 52

Diet Cardiovascular Disease Exercise Research 52

Cardiometabolic Health Congress

DECEMBER 7, 2023

This is due to several factors, including the aging of the population, a rise in obesity, increased detection, and increased survival with AF along with other forms of CVD. Background Atrial fibrillation, the most sustained common arrhythmia, is increasing in incidence and prevalence in the United States and globally.

Atrial Fibrillation 111

Atrial Fibrillation Risk Factors Ablation Stroke 111

Frontiers in Cardiovascular Medicine

JANUARY 29, 2025

In women, the eGFR remained unchanged only in those with chronic kidney disease (CKD) (n=10) and decreased in the absence of CKD (n=23) from 79.714.1 ConclusionsThe magnitude of the antihypertensive effect of RDN depends on signs of visceral obesity and, in men, also on the presence of CKD. In men, the eGFR did not change.

Obesity 52

Obesity Hypertension Kidney Disease Blood Pressure 52

Physiologically Speaking

MAY 3, 2024

It’s been well-established that males and females respond differently to exercise. This was also observed in the current analysis — in which 58% of the training-induced responses were different between the sexes.

Exercise 95

Exercise Physiology Research Kidney Disease 95

Cardiometabolic Health Congress

SEPTEMBER 13, 2024

Measuring eGFR and albuminuria is recommended for assessing kidney disease in all hypertensive patients. Below are some of the most notable highlights: 2024 ESC Updated Clinical Guidelines: Key updates include clopidogrel as a first-line option for long-term use after MI or PCI.

Hypertension 59

Hypertension Cardiovascular Disease Bicuspid/Mitral Arrhythmia 59

Stroke Journal

FEBRUARY 1, 2024

FD residents were significantly more likely to have comorbid hypertension (OR 1.14, 95%CI 1.09, 1.19), type 2 diabetes (OR 1.21, 95%CI 1.17, 1.25), heart failure (OR 1.14, 95%CI 1.09, 1.19), and chronic kidney disease (OR 1.24, 95%CI 1.18, 1.30) associated with acute stroke hospital admission.

Risk Factors 40

Risk Factors Stroke Strokes Health Disparities 40

Cardiometabolic Health Congress

JUNE 29, 2023

On Aug. (..)

Peripheral Arterial Disease 40

Peripheral Arterial Disease Education Webinar Kidney Disease 40

Cardiometabolic Health Congress

NOVEMBER 14, 2024

Cardiovascular disease remains the leading cause of death worldwide , claiming 18 million lives annually. 42% of adults are considered obese , increasing their risk of diabetes, hypertension, and cardiovascular issues. In the U.S.,

CME 103

CME Obesity Heart Failure Biomarkers 103